Aug 31-02, 2023    London, UK
5th International Conference on

Dementia and Dementia Care


Dementia and Brain Aging

Dementia is a chronic neurodegenerative disorder in which the complete deterioration of intellectual functioning and behavior occurs along with progressive memory loss. Brain aging is a natural process that occurs as we get older, but certain factors can accelerate the rate at which it occurs.

In this session, the main aim is to understand the overview of dementia and its impact in order to explore the current research and potential solutions for managing and preventing the disease. Secondly, brain aging, its risk factors, and causes are addressed, and the research interventions to promote healthy brain aging are concentrated. We will also explore the connection between dementia and brain aging.

Stages of Dementia

Dementia is a syndrome during which there is deterioration within the memory, which causes other problems within the brain. The stages of dementia can vary depending on the specific type and the individual, but generally, the progression can be divided into three main stages: early, middle, and late.

In this session, understanding the stages of dementia is important in order to provide proper care and support for individuals affected by the disease. We hope this session will give clear information on the stages of dementia, its progression at each stage, and the unique needs of individuals at each stage, which is the aim behind this session.

Neurology and Psychiatry

Neurology is the branch of medicine that deals with the diagnosis and treatment of disorders of the nervous system, including the brain and the spinal cord. Psychiatry, on the other hand, is the branch of medicine that deals with the diagnosis and treatment of mental illness, including mood and behavior disorders.

In this session, the latest research and developments in neurology and psychiatry related to dementia, the management of disease, and the role of neurology and psychiatry in taking care of patients with dementia, which includes the management of behavioral and psychological changes, are discussed. It will be a great opportunity for all professionals and researchers in psychiatry, neurology, geriatrics, and related fields to learn, network, and share insights with scholars and experts in their respective fields.

Neurological Brain Disorders

Neurological brain disorders are described as disorders that affect the brain as well as the nerves found throughout the human body and the spinal cord. Structural, biochemical, or electrical abnormalities in the brain, spinal cord, or other nerves can result in a range of symptoms.

In this session, various neurological brain disorders, their causes, early diagnosis, impact, and treatment procedures are discussed.

Neuropharmacology & Neurodegenerative Diseases

Neuropharmacology is a branch of medicine that studies medicines that affect the nervous system. It is focused on the development of compounds that may be of benefit to individuals who suffer from neurological or psychiatric illnesses. Neurodegenerative diseases are characterized by the progressive loss of nerve cells in the brain, leading to a decline in cognitive function.

In this session, an in-depth understanding of neuropharmacology and neurodegenerative diseases is provided, which paves the way for future research on futuristic improvements in treatment and care for the diseases.


Alzheimers Disease and Parkinsons Disease

Alzheimer's disease is a brain disorder that tentatively destroys memory and thinking skills, as well as the ability to carry out the simplest tasks. The exact cause of Alzheimer's disease is not known, but it is believed to be a combination of genetic, lifestyle, and environmental factors. Parkinson's disease is a disorder of the nervous system that affects movement. Symptoms include temblors, stiffness, and difficulty with connection and balance.

In this session, we will elaborately discuss the disease, ongoing research on diagnosis advancements, treatments, and developing therapies for both diseases, which will give a clear-cut idea about the diseases.

Huntington Disease

Huntington's disease, also known as HD, is a rare but debilitating genetic disorder that affects the brain and nervous system. It is a rare, inherited disorder that causes the progressive breakdown of nerve cells in the brain.

In this session, we will delve into the latest research and advancements in understanding and treating the disease. It also strikes a great opportunity to hear from leading experts in the field on Huntington's disease, early diagnosis, and recent advancements in treatments and care. It will also be a great opportunity for the attendees to gain knowledge about the disease and related topics to get a deeper understanding of the disease, its impact, and its relative measures to eliminate or lower the cause of the disease.

Dementia with Lewy bodies

Dementia with Lewy Bodies is a type of progressive dementia that affects 1–2% of the population over the age of 65. It is characterized by a combination of cognitive, motor, and behavioral symptoms that are caused by the presence of Lewy bodies, which are abnormal clumps of protein in the brain. 

In this session, we will discuss Dementia with Lewy Bodies, its symptoms, challenges in the diagnosis process, treatment, and care. Secondly, the session will focus on futuristic research on new techniques, imaging technologies for the diagnosis process, and new medications. It is necessary that healthcare professionals, researchers, and scholars are aware of the disease and its unique symptoms and treatments, which will be discussed in this session.

Microglia in Dementia

Microglia are known as the immune cells of the central nervous system. Microglia play an important role in the pathological process of Alzheimer's disease. Microglia are activated in the brains of individuals with Alzheimer's disease, and this also contributes to the formation of amyloid plaques and neurofibrillary tangles. 

This session will focus on microglia and its role in dementia and its related diseases in terms of progression, cause, etc. It will also explore recent research on the complex role of microglia in therapies and drugs, which will give the attendees a better understanding of microglia and its implication in dementia and related diseases.

Vascular dementia and strokes

Vascular dementia is a type of dementia caused by problems with the blood vessels that supply the brain. This type of dementia is often caused by strokes, which can damage the brain and lead to cognitive decline. Strokes are a leading cause of dementia. Research says stroke-affected people are at high risk of developing this type of dementia.

In this session, it is evident to discuss the latest research on vascular dementia and strokes, including risk factors, diagnosis, and treatment options including medications, therapies, and lifestyle changes that can help improve cognitive function and slow the progression of the disease. It will also be a great opportunity to hear from experts about their research and share their insights on the latest developments in the treatment of vascular dementia.

Frontotemporal Dementia

Frontotemporal dementia is a relatively rare form of dementia that affects the front and temporal lobes of the brain. These areas of the brain are responsible for controlling behavior, language, and decision-making. 

In this session, the latest research on frontotemporal dementia, including advances in understanding the underlying causes and potential treatments, is discussed. We hope that this conference will provide valuable information and resources for those affected by the disease and help raise awareness about the disease.

Semantic Dementia and Mixed Dementia

Semantic dementia, also known as primary progressive aphasia, is a type of frontotemporal dementia that affects the brain's ability to understand and use words. Mixed dementia, on the other hand, is a combination of Alzheimer's disease and another form of dementia, such as semantic dementia or Lewy body dementia. Individuals with mixed dementia may experience a combination of symptoms, such as memory loss, language difficulties, and visual hallucinations.

In this session, the latest research and treatment options for individuals with semantic and mixed dementia are discussed. We will also have a panel discussion with experts whose insights can be a great opportunity for individuals who have been affected by semantic and mixed dementia. It also gives attendees, healthcare individuals, and researchers a chance to gain insight and understanding of the disease, which is the goal of this session.

Mild Cognitive Impairment

Mild cognitive impairment is an early stage of memory loss or other cognitive capability loss which includes language or visual/spatial perception in people who maintain the ability to independently perform most activities of routine life. It is considered a risk factor for developing dementia, particularly Alzheimer's disease. 

In this session, we will discuss the latest research on mild cognitive impairment, including risk factors, diagnosis, and treatment options, as well as the use of early intervention and prevention strategies for individuals with impairment. Studies have shown that lifestyle changes, such as regular physical activity and a healthy diet, can help slow the progression of the impairment and reduce the risk of developing dementia. This conference will bring together leading experts in the field of dementia, including researchers, clinicians, and caregivers, to share the latest knowledge and best practices.

Amyloid Protein in Dementia

Amyloid proteins are a group of proteins that can form aggregates in the brain, leading to the formation of plaques. These plaques are a hallmark of Alzheimer's disease, the most common form of dementia. Amyloid beta is the specific protein that is believed to be responsible for the formation of plaques in Alzheimer's disease. 

In this session, discussions will focus on the latest research findings, the underlying mechanisms, potential therapies, new imaging techniques for diagnosis, and further research on the role of amyloid protein in dementia and its relative diseases. We hope that this session will provide valuable information on the related causes of the disease and the current state of research. We look forward to continued progress in the fight against dementia.

Tau Protein in Dementia

Tau protein is a microtubule-associated protein that is found in the brain. It plays a vital role in the structure and function of neurons, helping to maintain the stability and shape of nerve cells. However, in individuals with dementia, tau protein can become abnormal and form tangles that can damage and kill nerve cells.

In this session, we will delve into the role of tau protein in dementia and its causes, treatments, and valuable information on the latest research and developments surrounding tau protein in dementia, with the hope that it will inspire further research and advancements in the treatment of the disease.

Hearing Loss in Dementia

Hearing loss is a common problem in older adults and is even more prevalent in individuals with dementia. The main challenge in managing hearing loss in dementia is the difficulty in identifying and assessing the problem.

In this session, attendees will learn about the latest research on identifying and assessing hearing loss in dementia. They will also learn about its impact on the disease and its progression, as well as identification and communication strategies using assistive technology, which is the main aim of this session.

Movement Disorders and Dementia

Movement disorders are a group of neurological conditions that affect the ability to control and coordinate movement. One of the most common movement disorders associated with dementia is Parkinson's disease, which occurs due to the loss of dopamine-producing cells in the brain. There are also several other movement disorders that are associated with dementia, including progressive supranuclear palsy, and multiple system atrophy.

In this session, the discussion will be on movement disorders caused by dementia and its related diseases, as well as symptoms of the disease. Secondly, we will focus on the ongoing research on the underlying mechanisms that link dementia and movement disorders. It is essential for healthcare professionals, researchers, and attendees from related fields to be aware of the signs and symptoms of this complex link between dementia and movement disorders in order to develop effective treatments for the disease.

Dementia Models

Dementia is a complex and multifactorial disease, and different models have been developed to help understand its underlying mechanisms and test potential treatments. Dementia models mainly include animal models, computer models, and cellular or in vitro models, which are used by researchers to study dementia diseases.

In this session, we may discuss various dementia models that are used to study the effect, progression, and different factors such as genetics, environment, and lifestyle changes that contribute to the development of dementia. We hope this session will provide valuable information and insights to researchers, scientists, and healthcare professionals working in the field of dementia. It will also discuss the current and future developments in the field of dementia modeling and how they can aid in the understanding, diagnosis, and treatment of dementia.

Convergent Mechanisms across Dementia

Convergent Mechanisms Across Dementia will focus on the latest research and developments in understanding the underlying mechanisms of different types of dementia.

This session will bring together experts in the fields of neuroscience, psychiatry, and geriatrics to discuss the commonalities and differences in the underlying pathologies of dementia subtypes such as Alzheimer's disease, vascular dementia, and frontotemporal dementia, which paves the way for the attendees to network and share ideas with experts from a wide range of disciplines, including neuroscience, psychiatry, geriatrics, epidemiology, and genetics. This will include discussions on the use of non-pharmacological therapies, the role of carers and family members, and the need for policy and system changes to improve the lives of people living with dementia, which will provide an overview of the current state of research on dementia.

Modifiable Risk Factors

Modifiable risk factors refer to those factors that can be changed or controlled in order to reduce the risk of developing dementia. The major modifiable risk factors for dementia include high blood pressure, high cholesterol, diabetes, smoking, obesity, and poor cardiovascular health.

In this session, we will discuss the modifiable risk factors for dementia and the necessary steps to control the progression of the disease and avoid those risk factors.

Dementia Diagnosis and Its Recent Advancements

Dementia is a devastating condition that affects millions of people worldwide, and the early and accurate diagnosis of dementia is crucial for the management and treatment of the disease. Recent advancements in the diagnosis process include the use of biomarkers and cognitive tests. In addition to these advancements, there is also a growing interest in the use of mobile technologies and telemedicine in the diagnosis of dementia.

In conclusion, the diagnosis of dementia is a complex and challenging task, but recent advancements in the diagnosis process will help identify the early signs of the disease, which can speed up the treatment and care, which are elaborately discussed in this session.

Brain Stimulation and Imaging

Brain stimulation involves implanting electrodes that produce electrical impulses within certain areas of the brain to regulate abnormal impulses, although producing such impulses causes damage to certain cells and chemicals within the brain. Imaging techniques, such as magnetic resonance imaging and positron emission tomography, allow researchers to visualize changes in the brain that occur with dementia.

In this session, the importance of both brain stimulation and imaging, which are considered powerful tools in understanding the underlying causes of dementia and its further treatments, will be discussed.

Bioinformatics Approach for Dementia

Bioinformatics is the application of computational and statistical methods to the analysis of biological data. It uses large data sets, such as genetic information, to identify patterns and relationships that can inform the understanding and management of the disease.

In this session, we will discuss the bioinformatics approach and its importance in analyzing dementia diseases and their progression. It also focuses on the application of a bioinformatics approach to the identification of genetic information that can be used in understanding the underlying biology of the disease and developing new therapies, treatments, and management of the disease.

Biomarkers for dementia

Biomarkers are biological indicators that can be used to diagnose a specific condition or disease. In the case of dementia, biomarkers such as brain imaging, genetic testing, and cerebrospinal fluid analysis are being used to identify the early signs of the disease.

In this session, we will discuss dementia and the impact of the disease. It will also focus on the reliable need for biomarkers, current biomarkers, their advantages, and limitations. This session will also discuss current research on biomarker development and challenges in developing dementia. Then, the use of biomarkers and their significance which includes future advancements in order to improve the process of diagnosis and further prevention is discussed.

Novel Therapeutics and Drug Targets for Dementia

Novel therapeutics refers to new and innovative treatments that have the potential to improve the lives of individuals living with dementia. These can include drugs, devices, and other interventions that target specific mechanisms underlying the disease, including immune therapy, anti-inflammatory drugs, neuroprotective agents, and gene therapy.

In this session, it is discussed that the search for novel therapeutics and drug targets for dementia is a critical area of research that holds great promise for improving the lives of individuals living with this debilitating condition.

Design and Implementation of Clinical Trials & Case Reports

Clinical trials are essential for evaluating the safety and efficacy of new treatments for dementia. These studies involve recruiting participants and administering a specific intervention or medication to determine its effectiveness. Case reports provide detailed descriptions of the individual experiences of patients. These reports can be useful in identifying new treatment options or understanding how a specific treatment may affect different individuals.

In this session, we will discuss how the design and implementation of clinical trials can provide statistically significant results, but may not always provide a complete picture of how treatments may affect different individuals. Case reports, on the other hand, can provide detailed information about a specific individual's experience.

Dementia Nursing and Care

Dementia nursing and care is an essential aspect of providing care for individuals with dementia. Dementia is a progressive brain disorder that affects an individual's memory, thinking, and behavior. It is a challenging condition that requires specialized care, and nurses play a vital role in providing that care.

In this session, we will delve into the latest research and best practices in dementia nursing and care. We will discuss the various stages of dementia, including early onset, middle stage, and advanced stage, and the unique challenges that each stage presents. We will also explore the different types of dementia, such as Alzheimer's disease and vascular dementia, and the impact they have on an individual's life. Finally, dementia nursing and care is an important aspect of providing care for people with dementia. The main focus will be on the information regarding the latest research and best practices in dementia nursing and care, which will be discussed. It will also enrich them with a deeper understanding of the importance of person-centered care for individuals with dementia and the skills to provide that care.

Dementia Care and Policy

Dementia care and policy are two critical areas that are closely interlinked and have a significant impact on the lives of people with dementia and their families.

In this session, we invite experts in the field of dementia care and policy to discuss the latest research, best practices, the urge for early diagnosis of the disorder, and emerging trends in this area. Those care and policies include strategies for providing quality care for individuals living with dementia, technological and community-based improvements in care, and support for them. Overall, this session will provide a valuable opportunity for professionals in the field of dementia care and policy to come together, share knowledge, and collaborate on ways to improve the lives of individuals affected by dementia.

Dementia Rehabilitation

Dementia rehabilitation is an important aspect of caring for individuals with dementia, as it aims to improve their quality of life and maintain their independence. The focus of dementia rehabilitation is to help individuals with dementia maintain their cognitive, physical, and social abilities and manage the symptoms of their condition.

In this session, we will discuss various rehabilitation aspects that help individuals with dementia manage the disease. It will also focus on a number of strategies that will help the affected individuals improve their quality of life and maintain their independence.

Dementia care management

Dementia care management is a kind of cooperative care, defined as a complex intervention aiming to give optimal treatment and care for individuals with dementia and support carers using a computer-aided assessment to determine a personalized array of intervention modules and subsequent success monitoring.

In this session, we will discuss the latest research on best practices and strategies for dementia care management. It will also focus on addressing physical safety concerns, emotional and psychological needs, and therapies to manage dementia. It will also address the importance of providing a safe and supportive environment for individuals living with dementia to help manage dementia symptoms and improve their quality of life.

Prevention Measures and Awareness

Prevention measures and awareness are crucial in the fight against dementia. By understanding the risk factors for dementia and taking steps to reduce them, we can help prevent or delay the onset of the condition. Effective prevention measures include a healthy diet, regular fitness, managing chronic conditions, managing stress, etc.

In this session, we will discuss the importance of raising awareness about the signs and symptoms of dementia, as well as the available treatments and support options, which can be done through public education campaigns, community outreach programs, and support groups for those affected by dementia. With the right prevention measures and awareness raising, we can help reduce the impact of dementia on individuals and families around the world, which is discussed in this session.
Speakers Interview